McGinness; Kathleen

Patent Applications and Registrations

Patent applications and USPTO patent grants for McGinness; Kathleen.The latest application filed is for "anti-gpc3 chimeric antigen receptors (cars) in combination with trans co-stimulatory molecules and therapeutic uses thereof".

Company Profile

2.6.11

McGinness; Kathleen - Cambridge MA
MCGINNESS; Kathleen - Boston MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
ANTI-GPC3 CHIMERIC ANTIGEN RECEPTORS (CARs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOF App 20220054545 - McGinness; Kathleen ; et al.	2022-02-24
Chimeric Receptor Polypeptides In Combination With Trans Metabolism Molecules Modulating Intracellular Lactate Concentrations And Therapeutic Uses Thereof App 20210340219 - McGinness; Kathleen ; et al.	2021-11-04
Chimeric Antigen Receptor Polypeptides In Combination With Trans Metabolism Molecules Modulating Krebs Cycle And Therapeutic Uses Thereof App 20210332334 - McGinness; Kathleen ; et al.	2021-10-28
Chimeric Receptors In Combination With Trans Metabolism Molecules Enhancing Glucose Import And Therapeutic Uses Thereof App 20210261646 - MCGINNESS; Kathleen ; et al.	2021-08-26
Antibody-coupled T Cell Receptor Constructs And Therapeutic Uses Thereof App 20200181226 - MCGINNESS; Kathleen ; et al.	2020-06-11
Modified Chimeric Receptors And Uses Thereof In Immune Therapy App 20190112349 - McGinness; Kathleen ; et al.	2019-04-18
Chimeric receptors and uses thereof in immune therapy Grant 10,144,770 - Campana , et al. De	2018-12-04
Chimeric Receptors And Uses Thereof In Immune Therapy App 20180133252 - Wilson; Charles ; et al.	2018-05-17
Chimeric Receptors And Uses Thereof In Immune Therapy App 20170281682 - Wilson; Charles ; et al.	2017-10-05
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics Grant 8,598,327 - Schaub , et al. December 3, 2	2013-12-03
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeutics Grant 8,461,318 - Schaub , et al. June 11, 2	2013-06-11
Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics Grant 8,252,913 - Schaub , et al. August 28, 2	2012-08-28
Aptamers To Tissue Factor Pathway Inhibitor And Their Use As Bleeding Disorder Thereapeutics App 20120190834 - Schaub; Robert ; et al.	2012-07-26
Aptamers To Tissue Factor Pathway Inhibitor And Their Use As Bleeding Disorder Therapeutics App 20110281938 - Schaub; Robert ; et al.	2011-11-17
Aptamers to Tissue Factor Pathway Inhibitor and Their Use as Bleeding Disorder Therapeutics App 20110098345 - Schaub; Robert G. ; et al.	2011-04-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.